|
1
|
Rodrigo JP, García-Carracedo D, González
MV, Mancebo G, Fresno MF and García-Pedrero J: Podoplanin
expression in the development and progression of laryngeal squamous
cell carcinomas. Mol Cancer. 48:1–9. 2010.
|
|
2
|
Galli J, Cammarota G, Calò L, Agostino S,
D'Ugo D, Cianci R and Almadori G: The role of acid and alkaline
reflux in laryngeal squamous cell carcinoma. Laryngoscope.
112:1861–1865. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vineis P, Alavanja M, Buffler P, Fontham
E, Franceschi S, Gao YT, Gupta PC, Hackshaw A, Matos E, Samet J,
Sitas F, Smith J, Stayner L, Straif K, Thun MJ, Wichmann HE, Wu AH,
Zaridze D, Peto R and Doll R: Tobacco and cancer: recent
epidemiological evidence. J Natl Cancer Inst. 96:99–106. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hashibe M, Boffetta P, Zaridze D, Shangina
O, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Rudnai P and
Brennan P: Contribution of tobacco and alcohol to the high rates of
squamous cell carcinoma of the supraglottis and glottis in Central
Europe. Am J Epidemiol. 165:814–820. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hapner ER and Wise JC: Results of a
large-scale head and neck cancer screening of an at-risk
population. J Voice. 25:480–483. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Islami F, Tramacere I, Rota M, Bagnardi V,
Fedirko V, Scotti L, Garavello W, Jenab M, Corrao G, Straif K,
Negri E, Boffetta P and La Vecchia C: Alcohol drinking and
laryngeal cancer: overall and dose-risk relation - a systematic
review and meta-analysis. Oral Oncol. 46:802–810. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Morshed K: Association between human
papillomavirus infection and laryngeal squamous cell carcinoma. J
Med Virol. 82:1017–1023. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lewin JS and Gillenwater AM:
Characterization of laryngopharyngeal reflux in patients with
premalignant or early carcinomas of the larynx. Cancer.
97:1010–1014. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sereg-Bahar M, Jerin A and
Hocevar-Boltezar I: Higher levels of total pepsin and bile acids in
the saliva as a possible risk factor for early laryngeal cancer.
Radiol Oncol. 49:59–64. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sapkota A, Hsu CC, Zaridze D, Shangina O,
Szeszenia-Dabrowska N, Mates D, Fabiánová E, Rudnai P, Janout V,
Holcatova I, Brennan P, Boffetta P and Hashibe M: Dietary risk
factors for squamous cell carcinoma of the upper aerodigestive
tract in central and eastern Europe. Cancer Causes Control.
19:1161–1170. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ha SA, Shin SM, Namkoong H, Lee H, Cho GW,
Hur SY, Kim TE and Kim JW: Cancer-associated expression of
minichromosome maintenance 3 gene in several human cancers and its
involvement in tumorigenesis. Clin Cancer Res. 10:8386–8395. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Whitfield ML, George LK, Grant GD and
Perou CM: Common markers of proliferation. Nat Rev Cancer.
6:99–106. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Blow JJ and Gillespie PJ: Replication
licensing and cancer--a fatal entanglement? Nat Rev Cancer.
8:799–806. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bedkowska GE, Ławicki S and Szmitkowski M:
Molecular markers of carcinogenesis in the diagnostics of cervical
cancer. Postepy Hig Med Dosw (Online). 63:99–105. 2009.(in
Polish).
|
|
15
|
Giaginis C, Vgenopoulou S, Vielh P and
Theocharis S: MCM proteins as diagnostic and prognostic tumor
markers in the clinical setting. Histol Histopathol. 25:351–370.
2010.PubMed/NCBI
|
|
16
|
Leone G, DeGregori J, Yan Z, Jakoi L,
Ishida S, Williams RS and Nevins JR: E2F3 activity is regulated
during the cell cycle and is required for the induction of S phase.
Genes Dev. 12:2120–2130. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nowińska K and Dzięgiel P: The role of MCM
proteins in cell proliferation and tumorigenesis. Postepy Hig Med
Dosw (Online). 64:627–635. 2010.(in Polish).
|
|
18
|
Maiorano D, Lutzmann M and Méchali M: MCM
proteins and DNA replication. Curr Opin Cell Biol. 18:130–136.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tye BK and Sawyer S: The hexameric
eukaryotic MCM helicase: Building symmetry from nonidentical parts.
J Biol Chem. 275:34833–34836. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsuji T, Ficarro SB and Jiang W: Essential
role of phosphorylation of MCM2 by Cdc7/Dbf4 in the initiation of
DNA replication in mammalian cells. Mol Biol Cell. 17:4459–4472.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Honeycutt KA, Chen Z, Koster MI, Miers M,
Nuchtern J, Hicks J, Roop DR and Shohet JM: Deregulated
minichromosomal maintenance protein MCM7 contributes to oncogene
driven tumorigenesis. Oncogene. 25:4027–4032. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aparicio T, Guillou E, Coloma J, Montoya G
and Méndez J: The human GINS complex associates with Cdc45 and MCM
and is essential for DNA replication. Nucleic Acids Res.
37:2087–2095. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moyer SE, Lewis PW and Botchan MR:
Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for
the eukaryotic DNA replication fork helicase. Proc Natl Acad Sci
USA. 103:10236–10241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gerdes J, Lemke H, Baisch H, Wacker HH,
Schwab U and Stein H: Cell cycle analysis of a cell
proliferation-associated human nuclear antigen defined by the
monoclonal antibody Ki-67. J Immunol. 133:1710–1715.
1984.PubMed/NCBI
|
|
25
|
Czyzewska J, Guzińska-Ustymowicz K,
Pryczynicz A, Kemona A and Bandurski R: Immunohistochemical
evaluation of Ki-67, PCNA and MCM2 proteins proliferation index
(PI) in advanced gastric cancer. Folia Histochem Cytobiol.
47:289–296. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sarafoleanu D, Postelnicu V, Iosif C,
Manea C and Sarafoleanu C: The role of p53, PCNA and Ki-67 as
outcome predictors in the treatment of laryngeal cancer. J Med
Life. 2:219–226. 2009.
|
|
27
|
Chatrath P, Scott IS, Morris LS, Davies
RJ, Rushbrook SM, Bird K, Vowler SL, Grant JW, Saeed IT, Howard D,
et al: Aberrant expression of minichromosome maintenance protein-2
and Ki67 in laryngeal squamous epithelial lesions. Br J Cancer.
89:1048–1054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mukherjee G, Muralidhar B, Bafna UD,
Laskey RA and Coleman N: MCM immunocytochemistry as a first line
cervical screening test in developing countries: A prospective
cohort study in a regional cancer centre in India. Br J Cancer.
96:1107–1111. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gambichler T, Bischoff S, Bechara FG,
Altmeyer P and Kreuter A: Expression of proliferation markers and
cell cycle regulators in T cell lymphoproliferative skin disorders.
J Dermatol Sci. 49:125–132. 2008. View Article : Google Scholar
|
|
30
|
Tamura T, Shomori K, Haruki T, Nosaka K,
Hamamoto Y, Shiomi T, Ryoke K and Ito H: Minichromosome
maintenance-7 and geminin are reliable prognostic markers in
patients with oral squamous cell carcinoma: Immunohistochemical
study. J Oral Pathol Med. 39:328–334. 2010.PubMed/NCBI
|
|
31
|
MacCallum DE and Hall PA: The location of
pKi67 in the outer dense fibrillary compartment of the nucleolus
points to a role in ribosome biogenesis during the cell division
cycle. J Pathol. 190:537–544. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bullwinkel J, Baron-Lühr B, Lüdemann A,
Wohlenberg C, Gerdes J and Scholzen T: Ki-67 protein is associated
with ribosomal RNA transcription in quiescent and proliferating
cells. J Cell Physiol. 206:624–635. 2006. View Article : Google Scholar
|
|
33
|
Romero-Isart N, Jensen LT, Zerbe O, Winge
DR and Vasak M: Engineering of metallothionein-3 neuroinhibitory
activity into the inactive isoform metallothionein-1. J Biol Chem.
277:37023–37028. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ostrakhovitch EA, Olsson PE, von Hofsten J
and Cherian MG: P53 mediated regulation of metallothionein
transcription in breast cancer cells. J Cell Biochem.
102:1571–1583. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Dziegiel P: Expression of metallothioneins
in tumor cells. Pol J Pathol. 55:3–12. 2004.PubMed/NCBI
|
|
36
|
Werynska B, Pula B, Kobierzycki C,
Dziegiel P and Podhorska-Okolow M: Metallothioneins in the lung
cancer. Folia Histochem Cytobiol. 53:1–10. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Cherian MG and Kang YJ: Metallothionein
and liver cell regeneration. Exp Biol Med. 231:138–144. 2006.
|
|
38
|
Pastuszewski W, Dziegiel P, Krecicki T,
Podhorska-Okolow M, Ciesielska U, Gorzynska E and Zabel M:
Prognostic significance of metallothionein, p53 protein and Ki-67
antigen expression in laryngeal cancer. Anticancer Res. 27(1A):
335–342. 2007.PubMed/NCBI
|
|
39
|
Werynska B, Pula B, Muszczynska-Bernhard
B, Piotrowska A, Jethon A, Podhorska-Okolow M, Dziegiel P and
Jankowska R: Correlation between expression of metallothionein and
expression of Ki-67 and MCM-2 proliferation markers in non-small
cell lung cancer. Anticancer Res. 31:2833–2839. 2011.PubMed/NCBI
|
|
40
|
Wojnar A, Kobierzycki C, Krolicka A, Pula
B, Podhorska-Okolow M and Dziegiel P: Correlation of Ki-67 and
MCM-2 proliferative marker expression with grade of histological
malignancy (G) in ductal breast cancers. Folia Histochem Cytobiol.
48:442–446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sobin LH and Compton CC: TNM seventh
edition: What's new, what's changed. Communication from the
International Union Against Cancer and the American Joint Committee
on Cancer. 22:5336–5339. 2010.
|
|
42
|
Dziegiel P, Salwa-Zurawska W, Zurawski J,
Wojnar A and Zabel M: Prognostic significance of augmented
metallothionein (MT) expression correlated with Ki-67 antigen
expression in selected soft tissue sarcomas. Histol Histopathol.
20:83–89. 2005.
|
|
43
|
Remmele W and Stegner HE: Recommendation
for uniform definition of an immunoreactive score (IRS) for
immunohistochemical estrogen receptor detection (ER-ICA) in breast
cancer tissue. Pathologe. 8:138–140. 1987.(In German). PubMed/NCBI
|
|
44
|
Towbin H, Staehelin T and Gordon J:
Electrophoretic transfer of proteins from polyacrylamide gels to
nitrocellulose sheets: Procedure and some applications. Proc Natl
Acad Sci USA. 76:4350–4354. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gonzalez MA, Tachibana KE, Laskey RA and
Coleman N: Control of DNA replication and its potential clinical
exploitation. Nat Rev Cancer. 5:135–141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Rahmanzadeh R, Hüttmann G, Gerdes J and
Scholzen T: Chromophore-assisted light inactivation of pKi-67 leads
to inhibition of ribosomal RNA synthesis. Cell Prolif. 40:422–430.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Szelachowska J, Dziegiel P,
Jelen-Krzeszewska J, Jelen M, Matkowski R, Pomiecko A, Spytkowska
B, Jagas M, Gisterek I and Kornafel J: Mcm-2 protein expression
predicts prognosis better than Ki-67 antigen in oral cavity
squamocellular carcinoma. Anticancer Res. 26(3B): 2473–2478.
2006.PubMed/NCBI
|
|
48
|
Tokuyasu N, Shomori K, Nishihara K,
Kawaguchi H, Fujioka S, Yamaga K, Ikeguchi M and Ito H:
Minichromosome maintenance 2 (MCM2) immunoreactivity in stage III
human gastric carcinoma: Clinicopathological significance. Gastric
Cancer. 11:37–46. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Szajerka A, Dziegiel P, Szajerka T, Zabel
M, Winowski J and Grzebieniak Z: Immunohistochemical evaluation of
metallothionein, Mcm-2 and Ki-67 antigen expression in tumors of
the adrenal cortex. Anticancer Res. 28(5B): 2959–2965.
2008.PubMed/NCBI
|
|
50
|
Padmanabhan V, Callas P, Philips G,
Trainer TD and Beatty BG: DNA replication regulation protein Mcm7
as a marker of proliferation in prostate cancer. J Clin Pathol.
57:1057–1062. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chatrath P, Scott IS, Morris LS, Davies
RJ, Bird K, Vowler SL and Coleman N: Immunohistochemical estimation
of cell cycle phase in laryngeal neoplasia. Br J Cancer.
95:314–321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Fletcher RJ, Bishop BE, Leon RP, Sclafani
RA, Ogata CM and Chen XS: The structure and function of MCM from
archaeal M. Thermoautotrophicum. Nat Struct Biol. 10:160–167. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Forsburg SL: Eukaryotic MCM proteins:
Beyond replication initiation. Microbiol Mol Biol Rev. 68:109–131.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Thirumoorthy N, Shyam Sunder A,
Manisenthil Kumar K, Senthil Kumar M, Ganesh G and Chatterjee M: A
review of metallothionein isoforms and their role in
pathophysiology. World J Surg Oncol. 9:542011. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Scott IS, Morris LS, Rushbrook SM, Bird K,
Vowler SL, Burnet NG and Coleman N: Immunohistochemical estimation
of cell cycle entry and phase distribution in astrocytomas:
Applications in diagnostic neuropathology. Neuropathol Appl
Neurobiol. 31:455–466. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Guida T, Salvatore G, Faviana P, Giannini
R, Garcia-Rostan G, Provitera L, Basolo F, Fusco A, Carlomagno F
and Santoro M: Mitogenic effects of the up-regulation of
minichromosome maintenance proteins in anaplastic thyroid
carcinoma. J Clin Endocrinol Metab. 90:4703–4709. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Kebebew E, Peng M, Reiff E, Duh QY, Clark
OH and McMillan A: Diagnostic and prognostic value of cell-cycle
regulatory genes in malignant thyroid neoplasms. World J Surg.
30:767–774. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Dudderidge TJ, McCracken SR, Loddo M,
Fanshawe TR, Kelly JD, Neal DE, Leung HY, Williams GH and Stoeber
K: Mitogenic growth signalling, DNA replication licensing, and
survival are linked in prostate cancer. Br J Cancer. 96:1384–1393.
2007.PubMed/NCBI
|
|
59
|
Nishihara K, Shomori K, Tamura T, Fujioka
S, Ogawa T and Ito H: Immunohistochemical expression of geminin in
colorectal cancer: Implication of prognostic significance. Oncol
Rep. 21:1189–1195. 2009.PubMed/NCBI
|
|
60
|
Nowak M, Madej JA and Dziegiel P:
Correlation between MCM-3 protein expression and grade of
malignancy in mammary adenocarcinomas and soft tissue fibrosarcomas
in dogs. In Vivo. 23:49–53. 2009.PubMed/NCBI
|
|
61
|
Lee YS, Ha SA, Kim HJ, Shin SM, Kim HK,
Kim S, Kang CS, Lee KY, Hong OK, Lee SH, et al: Minichromosome
maintenance protein 3 is a candidate proliferation marker in
papillary thyroid carcinoma. Exp Mol Pathol. 88:138–142. 2010.
View Article : Google Scholar
|
|
62
|
Rodrigues RB, Motta RR, Machado SM,
Cambruzzi E, Zettler EW, Zettler CG and Jotz GP: Prognostic value
of the immunohistochemistry correlation of Ki-67 and p53 in
squamous cell carcinomas of the larynx. Rev Bras Otorrinolaringol
(Engl Ed). 74:855–859. 2008. View Article : Google Scholar
|
|
63
|
Theocharis S, Klijanienko J, Giaginis C,
Rodriguez J, Jouffroy T, Girod A, Point D, Tsourouflis G and
Sastre-Garau X: Metallothionein expression in mobile tongue
squamous cell carcinoma: Associations with clinicopathological
parameters and patient survival. Histopathology. 59:514–525. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Arriaga JM, Bravo IA, Bruno L, Morales
Bayo S, Hannois A, Sanchez Loria F, Pairola F, Huertas E, Roberti
MP, Rocca YS, et al: Combined metallothioneins and p53 proteins
expression as a prognostic marker in patients with Dukes stage B
and C colorectal cancer. Hum Pathol. 43:1695–1703. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Bukholm IR, Bukholm G, Holm R and Nesland
JM: Association between histology grade, expression of HsMCM2, and
cyclin A in human invasive breast carcinomas. J Clin Pathol.
56:368–373. 2003. View Article : Google Scholar : PubMed/NCBI
|
